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Abstract
Motivation: Numerous in silico methods predicting peptide binding to major histocompatibility
complex (MHC) class I molecules have been developed over the last decades. However, the multi-
tude of available prediction tools makes it non-trivial for the end-user to select which tool to use for
a given task. To provide a solid basis on which to compare different prediction tools, we here de-
scribe a framework for the automated benchmarking of peptide-MHC class I binding prediction
tools. The framework runs weekly benchmarks on data that are newly entered into the Immune
Epitope Database (IEDB), giving the public access to frequent, up-to-date performance evaluations
of all participating tools. To overcome potential selection bias in the data included in the IEDB, a
strategy was implemented that suggests a set of peptides for which different prediction methods
give divergent predictions as to their binding capability. Upon experimental binding validation,
these peptides entered the benchmark study.
Results: The benchmark has run for 15 weeks and includes evaluation of 44 datasets covering 17
MHC alleles and more than 4000 peptide-MHC binding measurements. Inspection of the results
allows the end-user to make educated selections between participating tools. Of the four participat-
ing servers, NetMHCpan performed the best, followed by ANN, SMM and finally ARB.
Availability and implementation: Up-to-date performance evaluations of each server can be found
online at http://tools.iedb.org/auto_bench/mhci/weekly. All prediction tool developers are invited to
participate in the benchmark. Sign-up instructions are available at http://tools.iedb.org/auto_bench/
mhci/join.
Contact: mniel@cbs.dtu.dk or bpeters@liai.org
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Cytotoxic T-cell lymphocytes (CTLs) play a pivotal role in the im-
mune control in vertebrates. CTLs scan the surface of cells and are
able to recognize and destroy cells harboring intracellular threats.
They do this by interacting with complexes of peptides and major
histocompatibility complex (MHC) class I molecules presented on
the cell surface.
Many events influence which peptides from a given non-self pro-
tein will become epitopes, including processing by the proteasome
and TAP (Androlewicz et al., 1993; Rock and Goldberg, 1999;
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Rock et al., 1994; Sijts and Kloetzel, 2011), peptide trimming
(Serwold et al., 2002; Weimershaus et al., 2013) and T-cell precur-
sor frequencies (Jenkins and Moon, 2012; Wang et al., 2007).
However, the single most selective event is binding to the MHC class
I (MHC-I) molecule (Yewdell and Bennink, 1999). Given this, large
efforts have been dedicated over the last decades to the development
of prediction methods capable of accurately predicting peptide bind-
ing to MHC-I molecules (Hattotuwagama et al., 2004; Hoof et al.,
2009; Karosiene et al., 2012; Lundegaard et al., 2008; Nielsen et al.,
2007; Shen et al., 2014; Wan et al., 2006).
The large number of different methods poses a significant chal-
lenge for the end-user in terms of selecting which method is most
suitable to solve a given question. Several articles have been pub-
lished with the aim of dealing with this, using different strategies
such as conducting a large-scale benchmark of prediction tools (Lin
et al., 2008a, 2008b; Zhang et al., 2009a, 2012), benchmarks where
prediction methods are trained and evaluated on identical datasets
(Peters et al., 2006), making large, static benchmark datasets avail-
able (Peters et al., 2006) or by hosting a machine learning competi-
tion that serves as a benchmark itself (Zhang et al., 2011).
Such large-scale benchmarks of prediction tools are essential for
researchers looking to make use of the predictions, as well as for
tool developers, as it allows them to evaluate how novel prediction
algorithms and training strategies increase predictive performance.
However, performing such benchmarks in an optimal manner,
where all participating methods are trained and evaluated on identi-
cal datasets, is a highly computationally complex task, limiting par-
ticipation to expert users. Another issue is the time lag between
when the benchmark is performed and when the manuscript describ-
ing the results is published. During this time, developers may have
updated or improved their prediction tools, meaning some of the
benchmark results are instantly outdated. Finally, when it comes to
static benchmark datasets, a risk of ‘overfitting’ exists leading to de-
velopment of sub-optimal methods lacking generalizability to novel
data. This is simply due to the fact that the same data are used re-
peatedly to evaluate and select the most optimal methods.
Another critical issue of benchmark studies relates to the trans-
parency of both the data used in the study and the evaluation meas-
ures. The machine learning competition in immunology (MLI) 2010
hosted by Zhang et al. (2011) was a well-supported competition,
gathering a total of 20 participating prediction tools. Likewise, the
2012 MLI competition attracted significant attention from the com-
munity with 32 submissions for the competition (bio.dfci.harvar-
d.edu/DFRMLI/HTML/natural.php). Being the first of their kind,
these benchmarks have been of high relevance for both users and de-
velopers of MHC-I binding prediction tools. However, for both end-
users and tool developers, certain aspects of the competitions were
sub-optimal. For instance, the benchmark data for the 2010 compe-
tition of MHC-I binding prediction methods were generated using a
commercial assay used in few academic settings with a criterion for
binding that could not readily be compared with more commonly
used KD/IC50/half-life data. Likewise, the MLI 2012 competition of
ligands eluted from MHC-I molecules did not clarify up front how
negative peptides would be chosen, how peptides for different
lengths would be dealt with, nor how the performance would be
scored. As participants in these competitions, we felt that it was un-
fortunate that this information was not provided up front and that
the best way to reduce such uncertainties was to completely auto-
mate the benchmarking process to make it completely transparent.
Here, we seek to provide a complimentary approach to bench-
marking prediction tools that addresses some of the issues listed
above. Our approach consists of two steps. First, we have developed
a framework for the automated benchmarking of MHC-I binding
prediction methods. Earlier similar approaches have been taken to
evaluate prediction of protein structure (Eyrich et al., 2001;
Kryshtafovych et al., 2014; Tai et al., 2014). The participating
methods are run via a RESTful web service (henceforth referred to
as servers) hosted locally for each participating method, making the
effort involved in joining the benchmark minimal for tool devel-
opers. The benchmark is run weekly on data newly submitted to the
Immune Epitope Database (IEDB) (Vita et al., 2010), thus making
the source and nature of the evaluation data fully transparent.
Furthermore, to achieve the maximum degree of transparency, the
benchmark evaluation criteria are outlined explicitly. The results of
all benchmark evaluations are made publicly available, giving the
public access to frequent, up-to-date performance evaluations of all
participating methods.
Second, to overcome the problem of selection bias in the data
that are included in the IEDB (which is often pre-selected based on
certain prediction algorithms), we have developed an approach that
selects a set of peptides that is highly informative in the sense that
different prediction methods disagree on how well the peptides
bind. We plan to run this approach once a year and test a set of the
resulting peptides. To provide complete transparency, the script se-
lecting the peptides in the benchmark will be made publically avail-
able. The script takes a list of peptides and returns a subset of the
peptides that should be measured experimentally. The resulting pep-
tides and measurements can then be submitted to the IEDB where
they will automatically be identified and included in the benchmark.
Every step from peptide selection to comparison of predicted and ex-
perimental values is performed without manual intervention.
2 Materials and methods
2.1 Participating prediction methods
Four prediction methods participated in the initial run of the auto-
mated MHC-I server benchmark. All the methods predict peptide-
MHC-I binding affinity and are trained on binding affinity data.
SMM (Peters and Sette, 2005), ANN (Lundegaard et al., 2008) and
ARB (Bui et al., 2005) are hosted at the La Jolla Institute for Allergy
& Immunology and NetMHCpan (Hoof et al., 2009) is hosted at
the Center for Biological Sequence Analysis at the Technical
University of Denmark. The different methods are described in de-
tail in the Supplementary Material.
2.2 Data
Data for the benchmark are retrieved from the IEDB. Because of the
nature of submissions to the IEDB, where journal articles are cura-
ted for peptide-MHC binding data, a multitude of measurement
data types are currently found in the IEDB database. To ensure that
as much data as possible can be included in the benchmark, we cur-
rently support five different measurement types: KD (thermo-
dynamic constant), IC50 (inhibitory concentration to outcompete
50% of a high affinity reference ligand, can approximate KD),
EC50 (concentration needed to half-saturate the receptor, approxi-
mates KD), t1/2 (half-life of binding) and binary (peptides solely
classified as positive or negative for binding based on some thresh-
old that is consistent within the curated reference). As IC50 and
EC50 measurements can approximate KD, these three data types are
combined and will be referred to as IC50 henceforth.
The benchmark is performed only on peptides of lengths 8–11
that are annotated to bind one of the MHC molecules available in
the NetMHCpan method. The benchmark therefore only includes
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measurements to exactly identified MHC molecules (excluding, for
instance, the imprecise serotype HLA-A2, which could refer to dif-
ferent HLA molecules identified by complete two-field typing such
as HLA-A*02:01 or HLA-A*02:06). NetMHCpan was chosen for
this filtering as this method provides predictions for by far the most
MHC molecules including all molecules covered by the other meth-
ods. A list of supported alleles can be found at: http://tools.iedb.org/
auto_bench/mhci/alleles.
The IEDB makes new data publically available on a weekly
basis, and the weekly benchmark is run on this new data prior to its
public release, ensuring that participating methods will not have the
opportunity to train on the benchmark data (except if a group has
access to the data outside of the IEDB).
2.3 Benchmark setup
The automated benchmark is set up in a decentralized fashion,
where each participating method is hosted externally as a RESTful
web service. We chose this type of setup because it grants the most
flexibility to participating developers. Developers are free to imple-
ment their prediction methods on their own servers and may make
changes to their implementations as they see fit. They may also re-
train their methods as often as they see fit and are indeed encour-
aged to do so. The IEDB releases datasets that were used to train the
predictions methods hosted on their site. These can be found at
http://tools.iedb.org/main/datasets/. Note that although the use of
the latest IEDB training dataset is encouraged, it is not a require-
ment for participation. Developers are also free to add data from
other sources to their own training datasets. The only requirements
for participants are that their web services must accept input and de-
liver output in defined formats. For RESTful web service templates
and other details, see http://tools.iedb.org/auto_bench/mhci/join.
Once data have been retrieved from the IEDB, each peptide and
the corresponding allele will be sent to each participating prediction
method in a customizable format and the benchmark server will re-
trieve the individual predictions. All measurements and predictions
are stored in databases on the benchmark server.
2.4 Evaluation
The data are split into homogenous evaluation datasets consisting of
unique combinations of measurement type, allele and length. As an
example, all peptides reported in a single reference that have length
10, were measured for binding to the MHC molecule HLA-A*02:01
and had their measurements reported as half-life make up one evalu-
ation dataset. An evaluation dataset must have at least 10 measure-
ment data points and at least two positive and two negative
measurement data points to be included in the benchmark. Each ser-
ver is evaluated on each evaluation dataset using the area under the
receiver operating curve (AUC) and the Spearman rank correlation
coefficient (SRCC). For AUC evaluations, continuous measurement
data are categorized as follows: for IC50 data, measurements less
than 500 nM are considered positive, for t1/2 data, measurements
over 2 h are considered positive. In the case of SRCC evaluations,
both continuous and binary measurement data were used.
For each evaluated dataset, a percentage rank score is calculated
for each participating server. The rank scores lie between 0 and 100,
with the best performing server scoring 100, the worst performing
server scoring 0 and the remaining servers receiving scores evenly
spaced between 0 and 100. Thus, for an evaluated dataset where
predictions for three servers are available, the scores 100, 50 and 0
are assigned. When predictions from four servers are available, the
scores 100, 67, 33 and 0 are assigned and so on. In the case of ties,
all methods receive the highest rank score. For example, in a bench-
mark with four servers where two servers have equal performance
and are ranked to be second best, the scores 100, 67, 67, and 0 are
assigned. Each server receives a percentage rank score based on its
AUC performance and a percentage rank score based on its SRCC
performance.
For each server, an overall ranking score is calculated, summariz-
ing its overall performance across all MHC molecules, peptide
lengths and measurement data types. The ranking score is calculated
as the average of the percentage rank scores of the individual evalu-
ation datasets covered by the given method. Evaluated datasets must
have predictions from at least two servers to be included in the cal-
culation of the ranking score. In addition to the overall ranking
score, AUC and SRCC ranking scores are also calculated and are
based solely on either AUC or SRCC performances, respectively.
Using this schema, servers are not penalized for only covering a sub-
set of the datasets included in the benchmark, yet servers that pro-
vide predictions for poorly understood MHC molecules with few
measurement data points available for training, are also not penal-
ized for doing so. When new data are benchmarked, each server re-
ceives both a weekly ranking score, based only on datasets
submitted that given week, and a cumulative ranking score that
takes into account datasets submitted within the past 3 months.
2.5 Generation of an information rich peptide dataset
As peptide data submitted to the IEDB might have a certain bias due
to selection strategies applied by the originating publications, we
included an additional dataset with large divergences between pre-
dicted binding values of different prediction servers to complement
the IEDB data. For this dataset, only 9mer peptides were included.
The peptide set was constructed to highlight differences in perform-
ance between the three best performing servers in the initial IEDB
benchmark (ANN, NetMHCpan and SMM). Predictions for 6000
unique 9mer peptides to HLA-A*02:01, HLA-B*07:02, HLA-
B*35:01, HLA-B*44:03, HLA-B*53:01 and HLA-B*57:01 were
generated from NetMHCpan, SMM and ANN. These predictions
were then used to assign each peptide a rank score for each server
and allele. In this case, we assigned the peptide with the strongest
predicted binding a rank score of 1.
Divergently predicted peptides were selected by comparing the
rank scores of the top 1% scoring peptides for a server with the rank
scores of the same peptides for each other server in a pairwise fash-
ion. For each pairwise comparison, the 10 peptides with the largest
difference in rank were selected for the performance test dataset.
This was repeated for each of the six MHC molecules. As we are
only comparing the top 1% scoring peptides for a server, comparing
server A with B is distinct from comparing server B with A and will
in most cases yield a new subset of peptides.
Although this selection scheme provides 60 data points (10 pep-
tides selected from each of the six pairwise method comparisons) to
compare servers per allele, in practice many of the selected peptides
provided data points for multiple pairwise comparisons at the same
time. For example, if servers A and B agree strongly in their predic-
tions for a peptide but disagree with server C, the same peptide pro-
vides a data point for both the A–C and B–C pairwise comparison.
Therefore, the number of unique divergently predicted peptides for
each allele was less than 60. The number of selected peptides per al-
lele ranged from 28 to 43, with a total of 208 being selected for all
six MHC molecules combined.
In addition to the set of divergently predicted peptides, we also
generated a set of peptides for which all servers tended to agree in
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their predictions of the peptides being strong binders, weak binders
or non-binders. The strong binders were selected by assigning each
peptide a single rank score equal to the worst rank score it achieved
across all three servers. As an example, a peptide that received the
ranks 1, 5 and 20 would be assigned the rank 20. Using this ranking,
the 10 highest ranked peptides were selected. All peptides selected,
apart from one, had rank scores in the top 2%. Weak binders were
selected by identifying peptides with rank scores within the 3–5%
interval for each of the three servers. Five of these peptides were
then selected randomly. For non-binders, a summed rank score was
calculated for each peptide by summing its rank scores from each
server. The five peptides with the numerically largest summed rank
scores were then selected. Using the approach, 20 peptides (10
strong binders, five weak binders and five non-binders) were se-
lected per allele. We term these peptides consistently predicted pep-
tides. Some of these peptides overlapped with the divergent peptides
and were discarded. In summary, a total of 104 consistently pre-
dicted peptides were added to the final dataset.
2.6 Binding affinity measurements
The peptide-MHC binding assay has been described in detail else-
where (Sidney et al., 2001). Briefly, purified MHC molecules, test
peptides and a radiolabeled probe peptide are incubated for 2 days
at room temperature in the presence of human B2-microglobulin
and a cocktail of protease inhibitors. After the 2-day incubation,
binding of the radiolabeled peptide to the corresponding MHC-I
molecule is determined by capturing peptide-MHC complexes on
W6/32 antibody (anti-HLA-A, B and C) coated plates and measur-
ing the bound cpm using a microscintillation counter.
3 Results
3.1 Initial IEDB benchmark
The automated MHC-I server benchmark was initially performed
on data added to the IEDB from January 1, 2013 to March 1, 2014.
During this time, 71 references containing MHC ligand assays were
added to the IEDB. These references were either direct submissions
to the IEDB or data curated from journal articles. The 71 IEDB ref-
erences were parsed for peptide binding affinity measurement data
with supported measurement types, MHC molecules and peptide
lengths. After filtering for peptides with appropriate lengths and
measurements against accepted MHC molecules, 36 datasets, from
12 different IEDB references, contained sufficient data to be eval-
uated. These 36 evaluated datasets contained 3791 peptide-MHC
measurements spread across 14 MHC molecules. Performance
scores for each server on these 36 datasets are listed in Table 1.
To summarize the overall performance of different methods, we
calculated percentage rank scores for each of the 33 datasets for
which predictions were made by two or more different methods
(Supplementary Table S1). As shown in the ranking scores depicted
in Figure 1, the ANN and NetMHCpan servers were the best per-
forming with comparable ranking scores, followed by SMM and fi-
nally ARB. Comparing the rank scores in Supplementary Table S1
to the absolute SRCC and AUC scores in Table 1, it becomes appar-
ent that averages over the ranks are preferable as an overall sum-
mary of relative prediction performance given the fact that not all
methods cover the same datasets. For example, the ARB server was
unable to provide predictions for three datasets covering the mol-
ecules HLA-C*07:01 and HLA-C*07:02. Only a small number of
training data are available for these MHC molecules, and as such, it
is expected that servers will perform poorly on these datasets, as was
indeed the case for the three other methods. Thus, methods attempt-
ing to make predictions for poorly characterized MHC molecules
would be punished unequally when considering average absolute
performance measures, while the use of rank scores, which are cen-
tered around 50 for all datasets, avoids this bias.
3.2 Weekly IEDB benchmarks
After the initial IEDB benchmark, the automated framework began
running weekly benchmarks on March 21, 2014. Figure 2 shows the
accumulative number of peptides benchmarked after each weekly
benchmark. In general, less than 20 measurements are added to the
IEDB each week, stemming from curated scientific literature. These
measurements are often distributed among different MHC mol-
ecules or lengths, or are measured using different assays, meaning
they are not large enough to meet the inclusion criteria for a bench-
mark dataset. This can be seen in Figure 2, as in most weeks, no new
data are included. However, based on past experience and the sub-
mission statistics from 2013, every 3–6 months a large amount of
data are added to the IEDB, often in a single submission. Data from
these large submissions make up the bulk of the measurement data
run by the automated benchmark. Figure 3 shows the number of
unique alleles in the automated benchmark with at least a single
evaluated dataset. The number of unique alleles will likely increase
with upcoming large data submissions to the IEDB.
Cumulative ranking scores for each participating server were cal-
culated each week during the first 2 months of automated weekly
benchmarks. The scores are plotted in Figure 4. As benchmarks are
run so frequently with the automated framework, there was a risk
that the top-performing server (which users will be recommended
for their prediction) also changes frequently. Figure 4 shows that
this is not the case, as each server’s position in terms of ranking
score is relatively stable. This is at least partially due to the fact that
during the first 2 months of weekly benchmarks, only seven new
datasets were benchmarked. This corresponds to roughly 20% of
the datasets present in the initial IEDB benchmark. As the cumula-
tive ranking score takes into account all datasets submitted within
the three previous months, the newly added datasets did not have
enough weight to significantly impact the performance rankings.
3.3 Dedicated dataset benchmark
The results above demonstrate that the continuous addition of data
to the IEDB provides a stream of benchmark datasets that can be
used to compare prediction performances of MHC-I binding predic-
tion methods in an automated manner. On the other hand, there are
downsides to relying on IEDB datasets for benchmarking. Peptides
in the IEDB datasets are often chosen because of their high predicted
affinity. It is thus possible that gaps in our knowledge remain for
peptides in poorly covered sequence spaces. Also, for many peptides,
all methods make very similar predictions, and such data points will
not help discriminate which methods perform better. To deal with
these issues, we generated a dedicated peptide dataset by making
predictions for a large number of peptides and asking which pep-
tides would be most information rich when it comes to differentiat-
ing between individual prediction methods (see Section 2 for
details). A total of 312 unique peptide-MHC combinations were se-
lected of which 208 were divergently predicted peptides and 104
were consistently predicted peptides (Supplementary Table S2). We
term this set of peptides the dedicated dataset. The peptides were
synthesized and binding affinities were measured for each peptide-
MHC combination and submitted to the IEDB as a regular data
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Table 1. Server performance values for the initial IEDB benchmark
IEDB reference Allele
Peptide
length
Peptide
count
Positive
count
Measurement
type
NetMHCpan SMM ANN ARB
SRCC AUC SRCC AUC SRCC AUC SRCC AUC
1026840 HLA-A*02:01 9 24 14 IC50 0.340 0.671 0.327 0.636 0.265 0.593 0.402 0.693
1026941 HLA-A*02:01 9 10 6 IC50 0.677 0.917 0.791 0.958 0.864 1.000 0.717 0.917
1026371 HLA-A*02:01 9 85 49 t1/2 0.559 0.812 0.557 0.811 0.576 0.819 0.563 0.811
1026840 HLA-A*02:01 9 24 7 t1/2 0.439 0.739 0.382 0.748 0.321 0.689 0.447 0.706
1026840 HLA-A*02:01 9 357 76 Binary 0.576 0.906 0.568 0.900 0.547 0.886 0.564 0.898
1026941 HLA-A*02:01 9 10 6 Binary 0.711 0.917 0.782 0.958 0.853 1.000 0.711 0.917
1026371 HLA-A*02:01 10 22 12 t1/2 0.152 0.567 0.144 0.558 0.191 0.583 0.106 0.533
1026891 HLA-A*11:01 9 22 19 Binary 0.094 0.579 0.115 0.596 0.136 0.614 0.115 0.404
1026840 HLA-A*24:02 9 20 12 IC50 0.209 0.667 0.400 0.771 0.209 0.635 0.046 0.500
1026840 HLA-A*24:02 9 357 49 Binary 0.444 0.873 0.405 0.839 0.438 0.868 0.404 0.836
1026891 HLA-A*24:02 9 21 16 Binary 0.129 0.587 0.000 0.500 0.037 0.525 0.000 0.500
1026840 HLA-A*30:01 9 349 8 Binary 0.160 0.809 0.151 0.791 0.141 0.771 0.108 0.708
1026840 HLA-A*30:02 9 56 35 IC50 0.011 0.483 0.121 0.569 0.134 0.601 0.269 0.661
1026840 HLA-A*30:02 9 56 14 t1/2 0.053 0.503 0.065 0.502 0.185 0.554 0.152 0.523
1026840 HLA-A*30:02 9 360 109 Binary 0.425 0.767 0.361 0.728 0.403 0.753 0.249 0.661
1026840 HLA-A*68:01 9 35 13 IC50 0.631 0.843 0.625 0.794 0.651 0.843 0.526 0.774
1026840 HLA-A*68:01 9 35 19 t1/2 0.316 0.322 0.425 0.253 0.407 0.266 0.385 0.308
1026840 HLA-A*68:01 9 436 43 Binary 0.385 0.873 0.374 0.863 0.383 0.871 0.336 0.791
1026371 HLA-B*07:02 9 43 17 t1/2 0.858 0.952 0.790 0.959 0.839 0.964 0.529 0.783
1026840 HLA-B*07:02 9 296 25 binary 0.375 0.889 0.387 0.903 0.385 0.899 0.366 0.880
1026371 HLA-B*07:02 10 25 9 t1/2 0.663 0.785 0.577 0.729 0.583 0.736 0.568 0.715
1026891 HLA-B*40:01 9 20 9 Binary 0.671 0.889 0.532 0.808 0.619 0.859 0.566 0.828
1026897 HLA-B*40:01 9 18 5 Binary 0.466 0.800 0.562 0.862 0.466 0.800 0.466 0.800
1026897 HLA-B*40:01 10 12 2 Binary 0.648 1.000 0.648 1.000 0.648 1.000 0.722 1.000
1026897 HLA-B*55:02 9 11 3 Binary 0.645 0.917 — — — — — —
1026840 HLA-B*58:01 9 35 17 IC50 0.362 0.716 0.319 0.668 0.267 0.650 0.209 0.546
1026840 HLA-B*58:01 9 35 5 t1/2 0.162 0.553 0.151 0.613 0.224 0.627 0.180 0.593
1026840 HLA-B*58:01 9 437 46 Binary 0.385 0.862 0.400 0.879 0.380 0.857 0.361 0.840
1026891 HLA-B*58:01 9 20 12 Binary 0.637 0.875 0.442 0.760 0.638 0.875 0.584 0.844
1026897 HLA-B*58:01 9 25 5 Binary 0.485 0.850 0.541 0.890 0.485 0.850 0.416 0.800
1026897 HLA-B*58:01 10 18 3 Binary 0.330 0.756 0.101 0.578 0.129 0.600 0.537 0.889
1026891 HLA-C*03:04 9 20 11 Binary 0.706 0.909 — — — — — —
1026840 HLA-C*07:01 9 18 12 IC50 0.181 0.542 0.013 0.389 0.166 0.611 — —
1026840 HLA-C*07:01 9 439 31 Binary 0.248 0.780 0.134 0.654 0.229 0.758 — —
1026891 HLA-C*07:02 9 20 7 Binary 0.245 0.648 0.391 0.736 0.409 0.747 — —
1026891 HLA-C*08:01 9 20 12 Binary 0.566 0.833 — — — — — —
Total: 3791 738 Average: 0.388 0.761 0.355 0.733 0.376 0.749 0.353 0.722
Each dataset has a unique combination of allele, peptide length and measurement type. Only datasets with a peptide count of at least 10 and at least 2 positive
and 2 negative measurements are reported.
Fig. 1. Ranking scores for the initial IEDB benchmark. The scores for each ser-
ver are calculated based on AUC performance, SRCC performance and both
performance measures
Fig. 2. The accumulated number of peptide-MHC measurements bench-
marked by the automated benchmarking framework during its first 2 months.
A total of 311 new measurements were identified and run during this time
period
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submission. The measurement data can be found online at: http://
www.iedb.org/refid/1028554.
Submitting the dedicated dataset to the IEDB triggered its inclu-
sion in the same prediction evaluation pipeline that is used for all
other IEDB submissions. AUC and SRCC performance metrics for
each server for five of the MHC molecules are listed in Table 2 and
corresponding percentage rank scores in Supplementary Table S3.
The HLA-B*53:01 dataset was automatically excluded from the
benchmark as none of the peptides in the dataset were measured to
be positive binders. The average rank scores for the dedicated data-
set are displayed in Figure 5 and show that ANN was the best per-
forming server with an overall ranking score of 70, followed by
NetMHCpan with 63, SMM with 53 and finally ARB with a low
score of 13.
Thus, the overall performance ranking of the methods in the
initial IEDB benchmark and the dedicated dataset benchmark is
in agreement. An interesting observation is that the SMM
method performed much better in terms of AUC than in terms of
SRCC performance. This trend was also true for the initial IEDB
benchmark above and was observed by us on other occasions previ-
ously. This suggests that the neural-network-based methods, com-
pared with the SMM method, are better at correctly ranking
individual peptides beyond the classification task into binders and
non-binders.
3.4 Online results
The automated MHC-I server benchmark is run weekly on new data
submitted to the IEDB. As such, server rankings are updated each
time a sufficient amount of new measurement data are identified
and run through the benchmark pipeline. Up-to-date performance
evaluations of each server can be found online at http://tools.iedb.
org/auto_bench/mhci/weekly/. A screenshot of the results page is
shown in Figure 6. The overall conclusion from running this bench-
mark for a period of 2 months is hence that the relative performance
ranking from best to worst of the four participating predictions
methods is NetMHCpan and ANN closely tied with overall ranking
scores of 67 and 66, respectively, followed by SMM with a score
of 48 and finally ARB with a score of 29. These results are based on
a large dataset covering 17 HLA alleles and more than 4000 pep-
tide-MHC measurements and are hence expected to be as un-
biased as possible given the fact that prediction methods in many
situations are used to guide peptide selection prior to experimental
validation.
Fig. 3. The number of unique alleles benchmarked by the automated bench-
marking framework
Fig. 4. The accumulated ranking score for each participating server, calcu-
lated after each weekly benchmark run during the first 2 months
Fig. 5. Ranking scores calculated based on performance values from the dedi-
cated dataset benchmark
Table 2. Server performance values for the dedicated dataset benchmark
IEDB
reference
Allele
Peptide
length
Peptide
count
Positive
count
Measurement
type
NetMHCpan SMM ANN ARB
SRCC AUC SRCC AUC SRCC AUC SRCC AUC
1028554 HLA-A*02:01 9 44 7 IC50 0.696 0.888 0.581 0.898 0.620 0.828 0.507 0.761
1028554 HLA-B*07:02 9 52 6 IC50 0.617 0.772 0.661 0.851 0.698 0.884 0.654 0.757
1028554 HLA-B*35:01 9 56 3 IC50 0.364 0.679 0.206 0.591 0.273 0.566 0.260 0.642
1028554 HLA-B*44:03 9 46 3 IC50 0.457 0.612 0.466 0.752 0.559 0.651 0.249 0.558
1028554 HLA-B*57:01 9 53 10 IC50 0.619 0.863 0.331 0.765 0.519 0.944 0.124 0.628
Total: 251 29 Average: 0.551 0.763 0.449 0.771 0.534 0.775 0.359 0.669
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4 Discussion
Prediction of peptide binding to MHC molecules has over the last
decades become a key and critical component of most rational epi-
tope discovery projects, and large efforts have been invested in de-
veloping methods with high accuracy in making such predictions.
Given the large number of available methods, it is difficult for the end
user to judge which method is optimal for a given task. Here, we have
designed a pipeline for the automated benchmarking of methods pre-
dicting peptide binding to MHC-I molecules, where methods are eval-
uated on data submitted to the IEDB prior to the data being made
publicly available. To enable easy access to participation in the bench-
mark, the requirements to join are limited to a minimum and partici-
pants are only required to set up and host a simple RESTful web
service. The benchmark is run on a weekly basis, and the results are
reported at a publicly available website in terms of both an overall
and easy interpretable performance score for each participating
method, as well as in terms of the detailed performance numbers for
each method for each benchmark dataset included in the evaluation.
This type of reporting makes the evaluation and calculation of evalu-
ation scores fully transparent to the community.
While setting up the automated benchmarking framework, we
chose to include only a limited set of methods initially. We chose
four representative methods, with two matrix-based methods (SMM
and ARB) and two neural-network-based methods (ANN and
NetMHCpan) where one was a pan-specific method. Moving for-
ward, we will add multiple additional methods, including
SMMPMBEC (Kim et al., 2009), an updated version of SMM that
has shown superior predictive performance compared with SMM in
previous benchmarks; IEDB consensus (Moutaftsi et al., 2006), the
consensus method currently recommended at the IEDB Analysis
Resource (Kim et al., 2012) as well as the consensus method
NetMHCcons (Karosiene et al., 2012) and the pan-specific method
PickPocket (Zhang et al., 2009b).
In creating a scoring scheme for the automated benchmark, we
wanted to utilize a metric that both accurately reflects performance
and is easily understood. For ease of comparison, we wanted to cre-
ate a single summary metric that allows users to compare two or
more methods. However, we acknowledge that a single summary
ranking will not in all situations accurately reflect performances. We
are currently aware of at least two weaknesses that may become
problematic in the future. As there is no penalty for not providing
predictions for any given allele, it is currently possible for a method
to obtain a high ranking score by opting to only participate on al-
leles for which the method is known to have a strong performance.
Although this is currently not a problem, we are prepared to alter
the scoring scheme if this becomes a practical issue. This will entail
introducing a set of ‘representative alleles’ for which a large amount
of training data are available and for which all participating meth-
ods must provide predictions or suffer a penalty. Another weakness
is that each dataset has an equal impact on the final ranking scores,
in spite of the fact that some datasets will inherently be more diffi-
cult to predict correctly than others (Kim et al., 2014). Inspired by
the evaluation strategy used in CASP (Cozzetto et al., 2009), we are
considering adding an evaluation weight to each dataset based on
the Z score of the performance evaluations. Thus, a dataset where
all methods have similar performances will be weighted low,
whereas a dataset where some methods perform well and others
poorly will be weighted high.
Another critical issue for the automated benchmark relates to
how performance should be reported for methods that join the
benchmark at different times. In the benchmarks described here, this
has not been a critical issue, as all methods have been part of the
automated benchmark from the beginning. In the future when novel
methods will join the benchmark at different time points, it is critical
to define how the performances of the different methods will be re-
ported. Ideally, the performance reported for the different methods
participating in the benchmark should be evaluated on an identical
dataset for the performance values to be comparable. On the other
hand, it would be important for the method developers joining the
benchmark to see the performance of their method compared with
others as quickly as possible. To deal with this issue, the following
enrollment and evaluation strategy has been implemented. The over-
all benchmark performance score is calculated in a time window of
3 months. Novel methods can join the benchmark at any point but
will only be included in the cumulative ranking comparison with
other methods after participating in the benchmark for 3 months.
This way, all methods are evaluated on identical datasets when it
comes to the overall ranking score. Performance measures on indi-
vidual datasets will be available with no time delay and all partici-
pating servers will receive weekly ranking scores as soon as new
data are benchmarked. An archive of historical benchmark datasets
and server evaluations is kept and made publicly available.
The results presented in Table 1 show that server performance
rankings may vary substantially between different datasets. For ex-
ample, of the six HLA-A*02:01 9mer datasets, ANN was the top
performing method for three datasets yet in last place for the other
three. Given the small size and heterogeneous sources of some data-
sets, such variability is not unexpected. We expect that the 3-month
accumulated ranking scores will help minimize the inherent per-
formance variations by giving users ranking scores based on a large
number of datasets. We strongly recommend that users refer to these
scores when choosing which prediction tool to use.
It is important to keep in mind that the ranking scores do not
provide information about the absolute predictive performance of
the methods. The scores are only meaningful in the context of each
Fig. 6. A screenshot of the results page for the automated MHC-I benchmark.
The individual dates may be clicked on to view detailed information on the
evaluation datasets benchmarked that week
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other, as they show how the methods rank among each other. For
example, a method with a ranking score of 100 is per definition the
best performing method across all datasets. However, the method
may have achieved this with AUC scores of 0.75 and SRCC scores
of 0.5, as long as the rest of the methods scored lower. On the other
hand, a method with a ranking score of 0 may still provide good pre-
dictions, the other methods simply performed better.
The benchmark has been running stably since March 2014 with
four participating prediction methods (SMM, ANN, NetMHCpan
and ARB). The overall conclusion taken from the benchmark results
is that the best performing method is NetMHCpan with an accumu-
lated overall ranking score of 67, followed by ANN with a score of
66, SMM scoring 48 and ARB scoring 29.
We believe this pipeline will be an important help for future pre-
diction tool developers as both the benchmark evaluation data and
predictions from all participating servers are made publicly available
to the community. Given the minimal effort involved in joining the
benchmark, we expect that the pipeline will act as the common
benchmark platform for evaluation of future peptide-MHC-I bind-
ing prediction methods. The use of a common benchmark platform
will be of significant importance to the end-user working within epi-
tope discovery, enabling an educated selection of which prediction
tool to use for the given task at hand.
This is the first automated benchmark platform developed
within the field of immunoinformatics. In the future, we expect to
expand the platform to cover other aspects of epitope identification,
including prediction of naturally processed ligands, T-cell epitopes
and B-cell epitopes.
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